Int J Biol Sci 2023; 19(11):3614-3627. doi:10.7150/ijbs.78660 This issue Cite

Research Paper

The role of CREG1 in megakaryocyte maturation and thrombocytopoiesis

HaiXu Song1#, Jiayin Li1,2#, Chengfei Peng1#, Dan Liu1, Zhu Mei1, Zheming Yang1,2, Xiaoxiang Tian1, Xiaolin Zhang1, Quanmin Jing1, Chenghui Yan1✉, Yaling Han1✉

1. National Key Laboratory of Frigid Zone Cardiovascular Disease, Cardiovascular Research Institute and Department of Cardiology, General Hospital of Northern Theater Command, Shenyang, China.
2. Northeastern University, Shenyang, China.
#Co-first authors

Citation:
Song H, Li J, Peng C, Liu D, Mei Z, Yang Z, Tian X, Zhang X, Jing Q, Yan C, Han Y. The role of CREG1 in megakaryocyte maturation and thrombocytopoiesis. Int J Biol Sci 2023; 19(11):3614-3627. doi:10.7150/ijbs.78660. https://www.ijbs.com/v19p3614.htm
Other styles

File import instruction

Abstract

Graphic abstract

Abnormal megakaryocyte maturation and platelet production lead to platelet-related diseases and impact the dynamic balance between hemostasis and bleeding. Cellular repressor of E1A-stimulated gene 1 (CREG1) is a glycoprotein that promotes tissue differentiation. However, its role in megakaryocytes remains unclear. In this study, we found that CREG1 protein is expressed in platelets and megakaryocytes and was decreased in the platelets of patients with thrombocytopenia. A cytosine arabinoside-induced thrombocytopenia mouse model was established, and the mRNA and protein expression levels of CREG1 were found to be reduced in megakaryocytes. We established megakaryocyte/platelet conditional knockout (Creg1pf4-cre) and transgenic mice (tg-Creg1). Compared to Creg1fl/fl mice, Creg1pf4-cre mice exhibited thrombocytopenia, which was mainly caused by inefficient bone marrow (BM) thrombocytopoiesis, but not by apoptosis of circulating platelets. Cultured Creg1pf4-cre-megakaryocytes exhibited impairment of the actin cytoskeleton, with less filamentous actin, significantly fewer proplatelets, and lower ploidy. CREG1 directly interacts with MEK1/2 and promotes MEK1/2 phosphorylation. Thus, our study uncovered the role of CREG1 in the regulation of megakaryocyte maturation and thrombopoiesis, and it provides a possible theoretical basis for the prevention and treatment of thrombocytopenia.

Keywords: CREG1, megakaryocyte differentiation, thrombopoiesis, MEK-ERK1/2 pathway


Citation styles

APA
Song, H., Li, J., Peng, C., Liu, D., Mei, Z., Yang, Z., Tian, X., Zhang, X., Jing, Q., Yan, C., Han, Y. (2023). The role of CREG1 in megakaryocyte maturation and thrombocytopoiesis. International Journal of Biological Sciences, 19(11), 3614-3627. https://doi.org/10.7150/ijbs.78660.

ACS
Song, H.; Li, J.; Peng, C.; Liu, D.; Mei, Z.; Yang, Z.; Tian, X.; Zhang, X.; Jing, Q.; Yan, C.; Han, Y. The role of CREG1 in megakaryocyte maturation and thrombocytopoiesis. Int. J. Biol. Sci. 2023, 19 (11), 3614-3627. DOI: 10.7150/ijbs.78660.

NLM
Song H, Li J, Peng C, Liu D, Mei Z, Yang Z, Tian X, Zhang X, Jing Q, Yan C, Han Y. The role of CREG1 in megakaryocyte maturation and thrombocytopoiesis. Int J Biol Sci 2023; 19(11):3614-3627. doi:10.7150/ijbs.78660. https://www.ijbs.com/v19p3614.htm

CSE
Song H, Li J, Peng C, Liu D, Mei Z, Yang Z, Tian X, Zhang X, Jing Q, Yan C, Han Y. 2023. The role of CREG1 in megakaryocyte maturation and thrombocytopoiesis. Int J Biol Sci. 19(11):3614-3627.

This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.
Popup Image